Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community (2015)
- Autores:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- Assuntos: QUIMIOTERAPIA (EFEITOS ADVERSOS); NEOPLASIAS COLORRETAIS (TERAPIA); TOXICIDADE
- Idioma: Inglês
- Imprenta:
- Local: Philadelphia
- Data de publicação: 2015
- Fonte:
- Título do periódico: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 33, n. 3S , abstr. 760, 2015
- Nome do evento: Gastrointestinal Cancers Symposium
-
ABNT
PROTASIO, Bruno Mendonca et al. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b. Acesso em: 24 abr. 2024. , 2015 -
APA
Protasio, B. M., Matutino, A. R. B., Lage, L. V., De Santana, I. A., Ramos, R. E. D. O., Caires-Lima, R., et al. (2015). Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b -
NLM
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2024 abr. 24 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b -
Vancouver
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2024 abr. 24 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b - Manual de condutas em oncologia
- Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1
- Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden Two case reports
- Young-age onset colorectal cancer in Brazil: analysis of incidence, clinical features, and outcomes in a tertiary cancer center
- Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
- Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome)
- "A individualização do tratamento possibilitará a cura dos tumores cancerígenos" [Entevista]
- O desafio de enfrentar o câncer usando com competência os melhores recursos ... [Prefácio]
- Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer
- Epidemiologia das pacientes com câncer de mama tratadas em um único centro público no Brasil
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas